Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
On May 14th, Era Biology will hold the online seminar for diagnosis and treatment of infectious disease. The professors from hospital in Jiangsu province and Anhui province are invited to attend th...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
Meet us in Dubai, Booth No. Z3 C19.
Dear customers,
Greetings from Era Biology.
We are pleased to invite you to the Medlab Middle East exhibition in Dubai.
The exhibition will take place on 6-9 Fe...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...